APG990

· Apogee Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APG990, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis [Phase 1]

See pricing